Thomas Klein
Impact in
- Biological Psychiatry top 0.5%
- Pharmacology top 0.02%
- Cannabis and Cannabinoid Research
Papers in
- Immunology 108
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 50
- Immune Cell Function and Interaction 32
- Immune Response and Inflammation 30
- Pharmacology 84
- Cannabis and Cannabinoid Research 60
- Inflammatory mediators and NSAID effects 21
- Co-authors
- Herman Friedman (145 shared papers)Catherine Newton (70 shared papers)Yoshimasa Yamamoto (49 shared papers)Cathy Newton (16 shared papers)Rolf M. Nüsing (15 shared papers)Michael Mark (17 shared papers)R Widen (29 shared papers)C. Newton (12 shared papers)
- Journals
- Infection and Immunity (37 papers)Advances in experimental medicine and biology (23 papers)Experimental Biology and Medicine (20 papers)Journal of Pharmacology and Experimental Therapeutics (10 papers)Zeitschrift für Soziologie (9 papers)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Thomas Klein
424 papers receiving 15.3k citations
Thomas Klein's Hit Papers
Peers
Comparison fields: 5 of 188
- Biological Psychiatry 690
- Pharmacology 4.6k
- Endocrinology 1.1k
- Endocrinology, Diabetes and Metabolism 2.7k
- Immunology 2.6k
Countries citing papers authored by Thomas Klein
This map shows the geographic impact of Thomas Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Klein more than expected).
Fields of papers citing papers by Thomas Klein
This network shows the impact of papers produced by Thomas Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Klein. The network helps show where Thomas Klein may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 448 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cannabinoid-based drugs as anti-inflammatory therapeutics Hit paper breakdown → | 2005 | 572 |
| 2 | Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors Hit paper breakdown → | 2011 | 502 |
| 3 | 2003 | 417 | |
| 4 | 2009 | 404 | |
| 5 | 2005 | 323 | |
| 6 | 1997 | 310 | |
| 7 | 2003 | 268 | |
| 8 | 2006 | 213 | |
| 9 | 2001 | 197 | |
| 10 | 1998 | 197 | |
| 11 | 2000 | 180 | |
| 12 | 1998 | 173 | |
| 13 | 1995 | 169 | |
| 14 | 2012 | 160 | |
| 15 | 1988 | 160 | |
| 16 | 1998 | 154 | |
| 17 | 1994 | 141 | |
| 18 | 1989 | 139 | |
| 19 | 1997 | 136 | |
| 20 | 2000 | 136 |
About Thomas Klein
Thomas Klein is a scholar working on Immunology, Pharmacology, Molecular Biology, Endocrinology and Endocrinology, Diabetes and Metabolism, having authored 448 papers that have together received 15.8k indexed citations. Recurring topics across this work include Legionella and Acanthamoeba research (77 papers), Cannabis and Cannabinoid Research (60 papers), Diabetes Treatment and Management (57 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (50 papers), Immune Cell Function and Interaction (32 papers), Immune Response and Inflammation (30 papers), Pancreatic function and diabetes (25 papers) and Inflammatory mediators and NSAID effects (21 papers). The work is most often cited by research in Biological Psychiatry (690 citations), Pharmacology (4.6k citations), Endocrinology (1.1k citations), Endocrinology, Diabetes and Metabolism (2.7k citations) and Immunology (2.6k citations). Thomas Klein has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Herman Friedman, Catherine Newton, Yoshimasa Yamamoto, Cathy Newton, Rolf M. Nüsing, Michael Mark, R Widen, C. Newton, Izabella Perkins and Herman Friedman. Their work appears in journals such as Infection and Immunity, Advances in experimental medicine and biology, Experimental Biology and Medicine, Journal of Pharmacology and Experimental Therapeutics and Zeitschrift für Soziologie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.